Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cianna gets $9m in debut financing round

This article was originally published in Clinica

Executive Summary

Aliso Viejo, California-based Cianna Medical has closed a $9m series A funding to expand commercialisation of its Savi breast brachytherapy applicator. Participants in the financing were Fog City Fund and Windamere Venture Partners - both were initial investors in BioLucent from which Cianni was spun out - and several private individuals. Cianni was created when BioLucent was acquired by Hologic in June 2007. Its Savi device is designed to deliver more targeted radiation therapy within the breast, thereby reducing the treatment time from 6-7 weeks to five days.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046402

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel